全文获取类型
收费全文 | 4074篇 |
免费 | 179篇 |
国内免费 | 16篇 |
专业分类
耳鼻咽喉 | 66篇 |
儿科学 | 94篇 |
妇产科学 | 22篇 |
基础医学 | 452篇 |
口腔科学 | 81篇 |
临床医学 | 218篇 |
内科学 | 793篇 |
皮肤病学 | 38篇 |
神经病学 | 464篇 |
特种医学 | 212篇 |
外科学 | 809篇 |
综合类 | 26篇 |
预防医学 | 82篇 |
眼科学 | 46篇 |
药学 | 269篇 |
中国医学 | 6篇 |
肿瘤学 | 591篇 |
出版年
2023年 | 27篇 |
2022年 | 54篇 |
2021年 | 70篇 |
2020年 | 46篇 |
2019年 | 51篇 |
2018年 | 81篇 |
2017年 | 60篇 |
2016年 | 71篇 |
2015年 | 66篇 |
2014年 | 78篇 |
2013年 | 114篇 |
2012年 | 202篇 |
2011年 | 213篇 |
2010年 | 132篇 |
2009年 | 128篇 |
2008年 | 183篇 |
2007年 | 212篇 |
2006年 | 225篇 |
2005年 | 200篇 |
2004年 | 205篇 |
2003年 | 173篇 |
2002年 | 193篇 |
2001年 | 136篇 |
2000年 | 132篇 |
1999年 | 150篇 |
1998年 | 46篇 |
1997年 | 52篇 |
1996年 | 42篇 |
1995年 | 57篇 |
1994年 | 34篇 |
1993年 | 37篇 |
1992年 | 85篇 |
1991年 | 84篇 |
1990年 | 74篇 |
1989年 | 57篇 |
1988年 | 51篇 |
1987年 | 52篇 |
1986年 | 62篇 |
1985年 | 53篇 |
1984年 | 37篇 |
1983年 | 35篇 |
1982年 | 22篇 |
1981年 | 13篇 |
1980年 | 15篇 |
1979年 | 28篇 |
1978年 | 16篇 |
1977年 | 12篇 |
1974年 | 14篇 |
1973年 | 17篇 |
1969年 | 13篇 |
排序方式: 共有4269条查询结果,搜索用时 15 毫秒
91.
92.
93.
94.
95.
Shiro Ono Kiyomi Yoshimoto Nobushiro Nishimura Ryo Yoneima Hiromasa Kawashima Tadanao Kobayashi Yoshiaki Tai Makiko Miyamoto Emiko Tsushima Noritaka Yada Kenji Nishio 《Internal medicine (Tokyo, Japan)》2021,60(8):1303
TAFRO syndrome is a systemic inflammatory, lymphoproliferative disorder, but the pathophysiology of the disease is unknown. It is typically characterized by thrombocytopenia, anasarca, a fever, reticulin fibrosis, renal dysfunction, and organomegaly. However, other manifestations have been also reported. We encountered a 43-year-old man with TAFRO syndrome who showed mediastinal panniculitis, liver damage, and adrenal lesions in addition to the core signs. He achieved complete remission with combination therapy of corticosteroids, tocilizumab, and cyclosporin, and remission was maintained even after drug discontinuation at 15 months. Atypical manifestations and complete remission of TAFRO syndrome were remarkable features of our case. 相似文献
96.
Masahito Yamamoto Kei Kitamura Masaaki Kasahara Masamitsu Serikawa Sakura Katumura Toshihito Yoshimoto Tadatoshi Matubayashi Kento Odaka Satoru Matsunaga Shinichi Abe 《Anatomical science international / Japanese Association of Anatomists》2017,92(3):364-372
The pterygoid process undergoes ossification of both the cartilage and membrane. However, few studies have attempted to explore the sequential development of the pterygoid process. Using histological examination, we performed morphological observations of the pterygoid process and surrounding tissue. ICR mice at embryonic days 13.5–18.0 and postnatal day 0 were used for morphological observations of the pterygoid process. By embryonic day 14.5, a mesenchymal cell condensation forming the anlage of the future medial pterygoid process differentiated into osteoid-like tissue and cartilage. At embryonic days 15.5–16.5, cartilage cells were clearly evident in the medial pterygoid process. In the medial pterygoid process, a bone collar was evident and calcified bone tissue surrounded the cartilage. At this point, a mesenchymal cell condensation formed the anlage of the pterygoid hamulus. At embryonic days 17.0–18.0, the cartilages were located along the lower and posterior border of the medial pterygoid process. A metachromatically stained matrix first became detectable around cells located in the pterygoid hamulus. On the other hand, at embryonic day 13.5, a metachromatically stained matrix was already evident in the space between the flattened cells in the lateral pterygoid process. At embryonic day 17.0, a hypertrophic cell zone had clearly formed in the diaphysis. On the basis of our present investigation, the lateral pterygoid process can be classified as primary cartilage, whereas the medial pterygoid process can be classified as secondary cartilage. Furthermore, it was found that the pterygoid hamulus is formed latest in the medial pterygoid process. 相似文献
97.
98.
99.
Domei T Yokoi H Kuramitsu S Soga Y Arita T Ando K Shirai S Kondo K Sakai K Goya M Iwabuchi M Ueeda M Nobuyoshi M 《Circulation journal》2012,76(2):423-429
100.
The N-terminal domain of thrombomodulin sequesters high-mobility group-B1 protein, a novel antiinflammatory mechanism 总被引:12,自引:0,他引:12 下载免费PDF全文
Abeyama K Stern DM Ito Y Kawahara K Yoshimoto Y Tanaka M Uchimura T Ida N Yamazaki Y Yamada S Yamamoto Y Yamamoto H Iino S Taniguchi N Maruyama I 《The Journal of clinical investigation》2005,115(5):1267-1274
Thrombomodulin (TM) is an endothelial anticoagulant cofactor that promotes thrombin-mediated formation of activated protein C (APC). We have found that the N-terminal lectin-like domain (D1) of TM has unique antiinflammatory properties. TM, via D1, binds high-mobility group-B1 DNA-binding protein (HMGB1), a factor closely associated with necrotic cell damage following its release from the nucleus, thereby preventing in vitro leukocyte activation, in vivo UV irradiation-induced cutaneous inflammation, and in vivo lipopolysaccharide-induced lethality. Our data also demonstrate antiinflammatory properties of a peptide spanning D1 of TM and suggest its therapeutic potential. These findings highlight a novel mechanism, i.e., sequestration of mediators, through which an endothelial cofactor, TM, suppresses inflammation quite distinctly from its anticoagulant cofactor activity, thereby preventing the interaction of these mediators with cell surface receptors on effector cells in the vasculature. 相似文献